Long COVID clinical trials a step in the right direction, but scale doesn’t match the need, researchers say

by

The National Institutes of Health has announced it was enrolling hundreds of people in phase 2 clinical trials that will evaluate at least four potential treatments for long COVID.

Leave A Comment

Your email address will not be published. Required fields are marked *